Gene Lay is the founder, president, and CEO of BioLegend, a global life science company based in San Diego. The company focuses on the development and production of high-quality antibodies for cellular immunity, inflammation, cancer, stem cells, and other reagents required for research and diagnosis. Since being founded in 2002, BioLegend has expanded its reach across the globe, with research and development facilities in Taiwan and Japan, as well as subsidiaries in Japan, Germany, the United Kingdom, and France. Lay continues to pursue his dream of giving back and cultivating more talents in Taiwan.

In May 2023, Lay donated US$100 million to Brigham and Women’s Hospital to establish The Gene Lay Institute of Immunology and Inflammation. The new institute will gather experts and scientists to develop new immunotherapies and conduct research on immune-mediated diseases, ageing and cancer.